biOasis Technologies Inc. Blood Brain Barrier Platform Attracts Majors - Midas Letter | NeuroImmunology | Scoop.it
biOasis Technologies Inc. (TSX.V:BTI) (OTCMKTS:BIOAF) use of peptides to transport therapeutic drugs across the blood brain barrier is attracting the attention of major biotech partners.

Via Krishan Maggon